505 related articles for article (PubMed ID: 33351885)
1. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis.
Wang Q; Oliver-Williams C; Raitakari OT; Viikari J; Lehtimäki T; Kähönen M; Järvelin MR; Salomaa V; Perola M; Danesh J; Kettunen J; Butterworth AS; Holmes MV; Ala-Korpela M
Eur Heart J; 2021 Mar; 42(12):1160-1169. PubMed ID: 33351885
[TBL] [Abstract][Full Text] [Related]
2. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
3. Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL).
Lee EC; Desai U; Gololobov G; Hong S; Feng X; Yu XC; Gay J; Wilganowski N; Gao C; Du LL; Chen J; Hu Y; Zhao S; Kirkpatrick L; Schneider M; Zambrowicz BP; Landes G; Powell DR; Sonnenburg WK
J Biol Chem; 2009 May; 284(20):13735-13745. PubMed ID: 19318355
[TBL] [Abstract][Full Text] [Related]
4. Effects of exercise training on ANGPTL3/8 and ANGPTL4/8 and their associations with cardiometabolic traits.
Hoffmann WG; Chen YQ; Schwartz CS; Barber JL; Dev PK; Reasons RJ; Miranda Maravi JS; Armstrong B; Gerszten RE; Silbernagel G; Konrad RJ; Bouchard C; Sarzynski MA
J Lipid Res; 2024 Feb; 65(2):100495. PubMed ID: 38160757
[TBL] [Abstract][Full Text] [Related]
5. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits.
Mehta N; Qamar A; Qu L; Qasim AN; Mehta NN; Reilly MP; Rader DJ
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1057-63. PubMed ID: 24626437
[TBL] [Abstract][Full Text] [Related]
6. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
[TBL] [Abstract][Full Text] [Related]
8. Association of Genetically Enhanced Lipoprotein Lipase-Mediated Lipolysis and Low-Density Lipoprotein Cholesterol-Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes.
Lotta LA; Stewart ID; Sharp SJ; Day FR; Burgess S; Luan J; Bowker N; Cai L; Li C; Wittemans LBL; Kerrison ND; Khaw KT; McCarthy MI; O'Rahilly S; Scott RA; Savage DB; Perry JRB; Langenberg C; Wareham NJ
JAMA Cardiol; 2018 Oct; 3(10):957-966. PubMed ID: 30326043
[TBL] [Abstract][Full Text] [Related]
9. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms.
Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q
J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia.
Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N
Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117
[TBL] [Abstract][Full Text] [Related]
11. Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism.
Kersten S
J Lipid Res; 2021; 62():100150. PubMed ID: 34801488
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
DiDonna NM; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4.
Bini S; D'Erasmo L; Astiarraga B; Minicocci I; Palumbo M; Pecce V; Polito L; Di Costanzo A; Haeusler RA; Arca M; Ferrannini E; Camastra S
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2647-2654. PubMed ID: 36163215
[TBL] [Abstract][Full Text] [Related]
15. A unified model for regulating lipoprotein lipase activity.
Zhang R; Zhang K
Trends Endocrinol Metab; 2024 Jun; 35(6):490-504. PubMed ID: 38521668
[TBL] [Abstract][Full Text] [Related]
16. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization.
Yau MH; Wang Y; Lam KS; Zhang J; Wu D; Xu A
J Biol Chem; 2009 May; 284(18):11942-52. PubMed ID: 19246456
[TBL] [Abstract][Full Text] [Related]
17. A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
Fowler A; Sampson M; Remaley AT; Chackerian B
Vaccine; 2021 Sep; 39(40):5780-5786. PubMed ID: 34474934
[TBL] [Abstract][Full Text] [Related]
18. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
Kersten S
Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
[TBL] [Abstract][Full Text] [Related]
20. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4.
Sonnenburg WK; Yu D; Lee EC; Xiong W; Gololobov G; Key B; Gay J; Wilganowski N; Hu Y; Zhao S; Schneider M; Ding ZM; Zambrowicz BP; Landes G; Powell DR; Desai U
J Lipid Res; 2009 Dec; 50(12):2421-9. PubMed ID: 19542565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
